Industry Watch
•  BTF Awarded AusIndustry START Grant
•  Benitec Granted First UK and US Patents for DNA Directed Gene Silencing
•  Amrad Corp. in Record Collaboration with Merck
•  Brief News
•  Guangzhou Baiyunshan Forms Alliance with Gist
•  Herbicure Secures Marketing Deal with Amrutanjan
•  ThinkGen Sets Up Biotech Incubation Fund
•  TNT India Enjoys Brisk Business as Biomedical Shipments Soar
•  Takeda's International Business Restructuring

Products/Services Highlight
•  Eisai Launches Chocola BB Plus
•  Taisho Pharmaceutical Introduces Suppository-Type Laxative

Research Findings
•  Major Breakthrough in Cancer Treatment
•  Zebrafish Model for Leukemia Research
•  Singapore Scientists Embark on Human Gene Study with the Zebrafish
•  Singapore May Soon Have the Answer to the Cure for SARS
•  Novel Liver Cancer Gene Identified
•  Orchid¡¯s Unique Nutrient Transformation Mechanism Revealed

Rules & Regulations
•  Kaipara Limits GE Organism Release
•  Philippines Tightens GMOs Rules
•  India to Approve GM Potato

Commentaries
•  Problems Faced in the Expansion of China's Health Supplementary Products Market
•  India: Popular Destination for Biotech Industry Investment in Asia Pacific
•  Singapore¡¯s Growing Biomedical Sector
•  Competitive Positioning Strategies for Australian Biotech Companies

General News
•  Competing Australian States to Co-Promote Aussie Biotech
•  New GM Wheat to Bypass Australia
•  Jiangsu Pharmaceutical Industry Thriving
•  Shenzhen Opens Drug Distribution Market to Foreign Investment
•  Vadodara to Establish Biotech Park
•  Monkey Pox Virus Imported to Japan
•  Increase in Non-Alcoholic Steatohepatitis Sufferers in Japan
•  Korea Free of SARS Suspects
•  Increasing Food Poisoning Cases
•  WHO Head Makes Smoking and AIDS Top Agenda
•  Upcoming Vaccine Facility in Malaysia
•  Bioinformatics Applied for Analyzing Brain Disorders
•  Completion of Trout Genetic Database by Year End

Global Development
•  Roche SARS Test Will Be Ready in July
•  Neurochem Reports Promising Findings from Alzhemed Phase II
Study for Alzheimier's Disease
•  Ocimum Biosolutions Collaborates with Hospital for Joint Diseases
•  The Institut Gustave-Roussy Teams with Agilent Technologies and Rosetta Biosoftware to Advance Cancer Research
•  SARS Outbreak Contained Worldwidep

Conference Calendar